$13.44
0.070.52%
At close: -
$13.11
-0.33-2.46%
After Hours: Jan 31, 8:05 AM EDT
Comments
Loading...
Entrada Therapeutics (NASDAQ:TRDA) Stock, Earnings Estimates, EPS, And Revenue
Entrada Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 12
EPS Estimate
$-0.660
Quarterly Revenue Estimate
$12.92M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$215.23M
Analyze the earnings history of Entrada Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Entrada Therapeutics (TRDA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-05 | $-0.35 | $-0.73 | 52.0 % |
| Q2 | 2024-08-13 | $1.55 | $0.14 | 1007.1 % |
| Q1 | 2024-05-07 | $0.68 | $-0.59 | 215.3 % |
| Q4 | 2024-03-13 | $-0.29 | $-0.17 | -70.6 % |
Entrada Therapeutics (TRDA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-05 | $19.57M | $12.32M | 58.9 % |
| Q2 | 2024-08-13 | $94.69M | $46.07M | 105.5 % |
| Q1 | 2024-05-07 | $59.12M | $14.98M | 294.7 % |
| Q4 | 2024-03-13 | $41.85M | $23.69M | 76.6 % |
FAQ
When is Entrada Therapeutics (NASDAQ:TRDA) reporting earnings?
Entrada Therapeutics (TRDA) is scheduled to report earnings on March 12, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
What were the latest earnings per share (EPS) for Entrada Therapeutics (NASDAQ:TRDA)?
The Actual EPS was $-0.35, which beat the estimate of $-0.73.
What were Entrada Therapeutics’s (NASDAQ:TRDA) revenues?
The Actual Revenue was $19.6M, which beat the estimate of $12.3M.
Browse earnings estimates, EPS, and revenue on all stocks.